Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review

How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR) following primary curative treatment is a controversial issue. Importantly, this prostate-specific antigen (PSA)-only recurrence is a surrogate neither of PCa-specific survival nor of overall survival. Physicians are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urologia internationalis 2018-04, Vol.100 (3), p.251-262
Hauptverfasser:	Artibani, Walter, Porcaro, Antonio Benito, De Marco, Vincenzo, Cerruto, Maria A., Siracusano, Salvatore
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Antigens Biochemistry Brachytherapy Cancer metastasis Cancer patients Cancer treatment Care and treatment Cryotherapy Humans Male Medical Oncology Neoplasm Metastasis Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - therapy Physicians Prostate cancer Prostate-Specific Antigen - analysis Prostatectomy Prostatic Neoplasms - pathology Prostatic Neoplasms - therapy Quality of Life Radiotherapy Recurrence Recurrence (Disease) Review Risk Salvage Therapy Surgery Treatment Outcome Ultrasonic Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!